TY - JOUR
T1 - C reactive protein levels are increased in non-allergic but not allergic asthma
T2 - A multicentre epidemiological study
AU - Ólafsdottir, I. S.
AU - Gislason, T.
AU - Thjodleifsson, B.
AU - Olafsson, Í
AU - Gislason, D.
AU - Jögi, R.
AU - Janson, C.
PY - 2005/6
Y1 - 2005/6
N2 - Background: High sensitivity C reactive protein (HsCRP) is an inflammatory marker known to be related to smoking, obesity, and cardiovascular disease. A study was undertaken to determine whether HsCRP is related to respiratory symptoms, asthma, atopy, and bronchial hyperresponsiveness in population samples from three countries. Methods: HsCRP was measured in 1289 subjects from three centres in ECRHS II: Reykjavik, Uppsala and Tartu. The HsCRP values ranged from <0.01 mg/l to 70.0 mg/l and were divided into four equal groups (≤0.45, 0.46-0.96, 0.97-2.21, and >2.21 mg/l). Results: HsCRP increased with increasing body mass index (r=0.41; p<0.0001) and was higher in smokers than in never smokers (p=0.02). A significant relationship was found between increased HsCRP levels and respiratory symptoms such as wheeze, attacks of breathlessness after effort, and nocturnal cough (p<0.0001). The crude odds ratio (95% CI) for the probability of non-allergic asthma was 3.57 (1.83 to 6.96) for subjects in the 4th quartile compared with the 1st quartile of HsCRP. This association remained significant after adjusting for study centre, age, sex, body weight, and smoking history (OR 2.19 (95% CI 1.04 to 4.63)). No significant relationship was observed between HsCRP and allergic asthma or bronchial responsiveness. Conclusions: Raised levels of HsCRP are significantly associated with respiratory symptoms and non-allergic asthma but not with allergic asthma.
AB - Background: High sensitivity C reactive protein (HsCRP) is an inflammatory marker known to be related to smoking, obesity, and cardiovascular disease. A study was undertaken to determine whether HsCRP is related to respiratory symptoms, asthma, atopy, and bronchial hyperresponsiveness in population samples from three countries. Methods: HsCRP was measured in 1289 subjects from three centres in ECRHS II: Reykjavik, Uppsala and Tartu. The HsCRP values ranged from <0.01 mg/l to 70.0 mg/l and were divided into four equal groups (≤0.45, 0.46-0.96, 0.97-2.21, and >2.21 mg/l). Results: HsCRP increased with increasing body mass index (r=0.41; p<0.0001) and was higher in smokers than in never smokers (p=0.02). A significant relationship was found between increased HsCRP levels and respiratory symptoms such as wheeze, attacks of breathlessness after effort, and nocturnal cough (p<0.0001). The crude odds ratio (95% CI) for the probability of non-allergic asthma was 3.57 (1.83 to 6.96) for subjects in the 4th quartile compared with the 1st quartile of HsCRP. This association remained significant after adjusting for study centre, age, sex, body weight, and smoking history (OR 2.19 (95% CI 1.04 to 4.63)). No significant relationship was observed between HsCRP and allergic asthma or bronchial responsiveness. Conclusions: Raised levels of HsCRP are significantly associated with respiratory symptoms and non-allergic asthma but not with allergic asthma.
UR - http://www.scopus.com/inward/record.url?scp=20444485838&partnerID=8YFLogxK
U2 - 10.1136/thx.2004.035774
DO - 10.1136/thx.2004.035774
M3 - Article
C2 - 15923243
AN - SCOPUS:20444485838
SN - 0040-6376
VL - 60
SP - 451
EP - 454
JO - Thorax
JF - Thorax
IS - 6
ER -